Effect of vaccination, comorbidities and age on mortality and severe disease associated with influenza during the season 2016–2017 in a Spanish tertiary hospital

Journal of Infection and Public Health

Volumn 12, Issue 4, 2019, Pages 486-491

  Gutiérrez González, Enrique ^a   Cantero Escribano, José M ^b   Redondo Bravo, Lidia ^b   San Juan Sanz, Isabel ^b   Robustillo Rodela, Ana ^b   Cendejas Bueno, Emilio ^b   Influenza Working Group, ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Comorbidity; Influenza vaccine; Influenza virus; Mortality; Severe influenza

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; DEMENTIA; DISEASE SEVERITY; EPIDEMIC; FATALITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA C; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SPAIN; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; AGE; EPIDEMIOLOGY; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VACCINATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; EPIDEMICS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; TERTIARY CARE CENTERS; VACCINATION;

EID: 85060079003     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2018.11.011     Document Type: Article

References (29)

1. Dushoff, J., Plotkin, J.B., Viboud, C., Earn, D.J.D., Simonsen, L., Mortality due to influenza in the United States–an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 163:January (2) (2006), 181–187.
2. Instituto de Salud Carlos III, Informe de Vigilancia de la Gripe en España. Temporada 2016-2017. 2017, Sistema de Vigilancia de la Gripe en España.
3. European Centre for Disease Prevention and Control, Influenza virus characterisation, summary Europe. June 2017. 2017, ECDC, Stockholm.
4. World Health Organization (WHO), Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. 2016, WHO, Geneva.
5. European monitoring of excess mortality for public health action European mortality bulletin week 3, 2017. 2017.
6. European Centre for Disease Prevention and Control, Communicable disease threats report CDTR Week 20, 14-20 May 2017., 2017.
7. European monitoring of excess mortality for public health action. European mortality bulletin week 10, 2017. 2017.
8. Kwok, K.O., Riley, S., Perera, R.A.P.M., Wei, V.W.I., Wu, P., Wei, L., et al. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1. BMC Infect Dis, 17(1), 2017, 337.
9. Centers for Disease Control and Prevention, People at high risk of developing flu–related complications. 2017.
10. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383.
11. Centro Nacional de Epidemiología, Vigilancia de casos graves hospitalizados confirmados de virus de la gripe. 2014.
12. Red Nacional de Vigilancia Epidemiológica, Guía de procedimientos para la vigilancia de gripe en España. Sistema de vigilancia de la gripe en España. 2014, Instituto de Salud Carlos III. Octubre.
13. DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:September (3) (1988), 837–845.
14. Puig-Barberà, J., Natividad-Sancho, A., Trushakova, S., Sominina, A., Pisareva, M., Ciblak, M.A., et al. Epidemiology of hospital admissions with influenza during the 2013/2014 Northern Hemisphere influenza season: results from the global influenza hospital surveillance network. PLoS One, 11(5), 2016, e0154970.
15. Rodríguez-Baño, J., Paño-Pardo, J.R., Rubio, E.M., Porta, F.S., Pregnancy, obesity and other risk factors for complications in influenza A (H1N1) pdm09 infection. Enferm Infecc Microbiol Clin 30 (2012), 32–37.
16. Naumova, E.N., Parisi, S.M., Castronovo, D., Pandita, M., Wenger, J., Minihan, P., Pneumonia and influenza hospitalizations in elderly people with dementia. J Am Geriatr Soc 57:December (12) (2009), 2192–2199.
17. Brandeis, G.H., Berlowitz, D.R., Coughlin, N., Mortality associated with an influenza outbreak on a dementia care unit. Alzheimer Dis Assoc Disord, 12(3), 1998.
18. Mortensen, E.M., Coley, C.M., Singer, D.E., Marrie, T.J., Obrosky, D.S., Kapoor, W.N., et al. Causes of death for patients with community-acquired pneumonia: results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 162:May (9) (2002), 1059–1064.
19. Shen, H.-N., Lu, C.-L., Li, C.-Y., Dementia increases the risks of acute organ dysfunction severe sepsis and mortality in hospitalized older patients: a national population-based study. PLoS One, 7(August (8)), 2012, e42751.
20. Bourne, J., Improving services and support for people with dementia, 7, 2007, National Audit Office.
21. Viasus, D., Paño-Pardo, J.R., Pachón, J., Campins, A., López-Medrano, F., Villoslada, A., et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 17:May (5) (2011), 738–746.
22. Skowronski, D.M., Janjua, N.Z., De Serres, G., Sabaiduc, S., Eshaghi, A., Dickinson, J.A., et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One, 9(3), 2014, e92153.
23. Wu, N.C., Zost, S.J., Thompson, A.J., Oyen, D., Nycholat, C.M., McBride, R., et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog, 13(10), 2017, e1006682.
24. Jia, N., Li, C., Liu, Y.-X., Richardus, J.H., Feng, D., Yang, H., et al. Lower cellular immune responses to influenza A (H3N2) in the elderly. J Med Virol 81:August (8) (2009), 1471–1476.
25. Lang, P.-O., Govind, S., Mitchell, W.A., Siegrist, C.-A., Aspinall, R., Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev 10:3 (2011), 389–395.
26. Rondy, M., Castilla, J., Launay, O., Costanzo, S., Ezpeleta, C., Galtier, F., et al. Moderate influenza vaccine effectiveness against hospitalisation with A (H3N2) and A (H1N1) influenza in 2013-14: Results from the InNHOVE network. Hum Vaccin Immunother 12:5 (2016), 1217–1224.
27. Castilla, J., Godoy, P., Domínguez, Á., Martínez-Baz, I., Astray, J., Martín, V., et al. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 57:2 (2013), 167–175.
28. Arriola, C.S., Anderson, E.J., Baumbach, J., Bennett, N., Bohm, S., Hill, M., et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012- 2013 season in the United States. J Infect Dis 212:8 (2015), 1200–1208.
29. Gutiérrez-Pizarraya, A., Pérez-Romero, P., Alvarez, R., Aydillo, T.A., Osorio-Gomez, G., Milara-Ibanez, C., et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect 65:5 (2012), 423–430.